Abstract
Mohs Micrographic Surgery (MMS) provides the highest cure rate for the treatment of BCC whilst maximising tissue conservation. Key to the success of MMS is the correct diagnosis of tumour. However, the facial area has a high density of follicular and sebaceous epithelia which can be difficult to distinguish from BCC. Folliculocentric basaloid proliferation (FBP) is a term which attempts to define these abnormal follicular entities, sometimes misdiagnosed as BCC. This was first described in a group of patients undergoing MMS for nasal and perinasal BCC, however the frequency is unreported.1
This article is protected by copyright. All rights reserved.
http://ift.tt/2drV02W
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου